Yuji Wang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 27

Top Topics

Hyaluronic Acid

Electron Microscopy

Top Venues

Molecules (Basel, Switzerland)

International journal of nanomedicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Lu, Di Zhu, Bo Hu, Rong Chen, Xin Wang, Xiaoxue Xu, Wenjing Wang, Hao Wu, Yuji Wang
pH-Responsive, Self-Assembled Ruthenium Nanodrug: Dual Impact on Lysosomes and DNA for Synergistic Chemotherapy and Immunogenic Cell Death. Small (Weinheim an der Bergstrasse, Germany) 20 (24) (2024)
Jie Zhong, Ruiqi Zhao, Yuji Wang, Yu-Xiong Richard Su, Xinmiao Lan
Nano-PROTACs: state of the art and perspectives. Nanoscale 16 (9) (2024)
Yijiang Jia, Renbo Jia, Ayijiang Taledaohan, Yanming Wang, Yuji Wang
Structure-Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy. Pharmaceutics 16 (3) (2024)
Di Zhu, Yu Lu, Zhanchao Yan, Qian Deng, Bo Hu, Yinsong Wang, Wenjing Wang, Yanming Wang, Yuji Wang
A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer. Journal of medicinal chemistry 67 (10) (2024)
Jie Zhong, Ruiqi Zhao, Yuji Wang, Yu-Xiong Richard Su, Xinmiao Lan
Nano-PROTACs: state of the art and perspectives. Nanoscale 16 (9) (2024)
Jie Zhong, Ruiqi Zhao, Yuji Wang, Yu-Xiong Richard Su, Xinmiao Lan
Nano-PROTACs: state of the art and perspectives. Nanoscale (2024)
Yu Lu, Di Zhu, Bo Hu, Rong Chen, Xin Wang, Xiaoxue Xu, Wenjing Wang, Hao Wu, Yuji Wang
pH-Responsive, Self-Assembled Ruthenium Nanodrug: Dual Impact on Lysosomes and DNA for Synergistic Chemotherapy and Immunogenic Cell Death. Small (Weinheim an der Bergstrasse, Germany) (2024)
Di Zhu, Yu Lu, Zhanchao Yan, Qian Deng, Bo Hu, Yinsong Wang, Wenjing Wang, Yanming Wang, Yuji Wang
A β-Carboline Derivate PAD4 Inhibitor Reshapes Neutrophil Phenotype and Improves the Tumor Immune Microenvironment against Triple-Negative Breast Cancer. Journal of medicinal chemistry (2024)
Yijiang Jia, Renbo Jia, Ayijiang Taledaohan, Yanming Wang, Yuji Wang
Structure-Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy. Pharmaceutics 16 (3) (2024)
Yijiang Jia, Renbo Jia, Ayijiang Taledaohan, Yanming Wang, Yuji Wang
Structure-Activity Relationship of PAD4 Inhibitors and Their Role in Tumor Immunotherapy. Pharmaceutics 16 (3) (2024)
Shangyan Gu, Yu Lu, Yuji Wang, Wensheng Lu, Wei Wang
Low Molecular Weight Hydrogel for Wound Healing. Pharmaceutics 15 (4) (2023)
Shangyan Gu, Yu Lu, Yuji Wang, Wensheng Lu, Wei Wang
Low Molecular Weight Hydrogel for Wound Healing. Pharmaceutics 15 (4) (2023)
Cong Liu, Lin Gui, Jia-Jia Zheng, Yong-Qiang Xu, Benli Song, Li Yi, Yijiang Jia, Ayijiang Taledaohan, Yuji Wang, Xuejiao J Gao, Zeng-Ying Qiao, Hao Wang, Zhiyong Tang
Intrinsic Strain-Mediated Ultrathin Ceria Nanoantioxidant. Journal of the American Chemical Society (2023)
Bo Hu, Jinyuan Gao, Yu Lu, Yuji Wang
Applications of Degradable Hydrogels in Novel Approaches to Disease Treatment and New Modes of Drug Delivery. Pharmaceutics 15 (10) (2023)
Bingru Liu, Yu Lu, Ayijiang Taledaohan, Shi Qiao, Qingyan Li, Yuji Wang
The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors. Molecules (Basel, Switzerland) 29 (1) (2023)
Shuangling Chen, Meng Liang, Chengli Wu, Xiaoyi Zhang, Yuji Wang, Ming Zhao
Poly- α , β - d , l -Aspartyl-Arg-Gly-Asp-Ser-Based Urokinase Nanoparticles for Thrombolysis Therapy. Molecules (Basel, Switzerland) 28 (6) (2023)
Shangyan Gu, Yu Lu, Yuji Wang, Wensheng Lu, Wei Wang
Low Molecular Weight Hydrogel for Wound Healing. Pharmaceutics 15 (4) (2023)
Shuangling Chen, Meng Liang, Chengli Wu, Xiaoyi Zhang, Yuji Wang, Ming Zhao
Poly- α , β - d , l -Aspartyl-Arg-Gly-Asp-Ser-Based Urokinase Nanoparticles for Thrombolysis Therapy. Molecules (Basel, Switzerland) 28 (6) (2023)
Shangyan Gu, Yu Lu, Yuji Wang, Wensheng Lu, Wei Wang
Low Molecular Weight Hydrogel for Wound Healing. Pharmaceutics 15 (4) (2023)
Yu Lu, Di Zhu, Liujia Chan, Bo Hu, MarMar Tuohan, Li Li, Wei Wang, Yuji Wang
The ruthenium complex assists in nuclear targeting and selective killing of tumor cells. Nanoscale (2023)
Bingru Liu, Yu Lu, Ayijiang Taledaohan, Shi Qiao, Qingyan Li, Yuji Wang
The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors. Molecules (Basel, Switzerland) 29 (1) (2023)
Shuangling Chen, Meng Liang, Chengli Wu, Xiaoyi Zhang, Yuji Wang, Ming Zhao
Poly- α , β - d , l -Aspartyl-Arg-Gly-Asp-Ser-Based Urokinase Nanoparticles for Thrombolysis Therapy. Molecules (Basel, Switzerland) 28 (6) (2023)
Yu Lu, Di Zhu, Quynh Le, Yuji Wang, Wei Wang
An NMR Study on Hydration and Molecular Interaction of Phytantriol-Based Liquid Crystals. Pharmaceutics 14 (11) (2022)
Yu Lu, Di Zhu, Quynh Le, Yuji Wang, Wei Wang
Ruthenium-based antitumor drugs and delivery systems from monotherapy to combination therapy. Nanoscale 14 (44) (2022)
Yu Lu, Di Zhu, Lin Gui, Yuanming Li, Wenjing Wang, Jiawang Liu, Yuji Wang
A dual-targeting ruthenium nanodrug that inhibits primary tumor growth and lung metastasis via the PARP/ATM pathway. Journal of nanobiotechnology 19 (1) (2021)
Yu Lu, Zidong Peng, Di Zhu, Yijiang Jia, Ayijiang Taledaohan, Yuanming Li, Jiawang Liu, Yanming Wang, Yuji Wang
RGD Peptide and PAD4 Inhibitor-Loaded Gold Nanorods for Chemo-Photothermal Combined Therapy to Inhibit Tumor Growth, Prevent Lung Metastasis and Improve Biosafety. International journal of nanomedicine 16 (2021)
Songlin Song, Lin Gui, Qiqi Feng, Ayijiang Taledaohan, Yuanming Li, Wei Wang, Yanming Wang, Yuji Wang
TAT-Modified Gold Nanoparticles Enhance the Antitumor Activity of PAD4 Inhibitors. International journal of nanomedicine 15 (2020)